microarray-grade epoxy-coated glass slide schott ag mainz, germany (SCHOTT)
90
Structured Review
SCHOTT
microarray-grade epoxy-coated glass slide schott ag mainz, germany
Microarray Grade Epoxy Coated Glass Slide Schott Ag Mainz, Germany, supplied by SCHOTT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-grade+epoxy-coated+glass+slide+schott+ag+mainz/microarray+grade+epoxy+coated+glass+slide+schott+ag+mainz++germany/pmc08578614-201-18-20
Average 90 stars, based on 1 article reviews
Microarray Grade Epoxy Coated Glass Slide Schott Ag Mainz, Germany, supplied by SCHOTT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-grade+epoxy-coated+glass+slide+schott+ag+mainz/microarray+grade+epoxy+coated+glass+slide+schott+ag+mainz++germany/pmc08578614-201-18-20
Average 90 stars, based on 1 article reviews
microarray-grade epoxy-coated glass slide schott ag mainz, germany - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Filtration:Article Title: Glycoconjugate microarray based on an evanescent-field fluorescence-assisted detection principle for investigation of glycan-binding proteins. Article Snippet: After filtration using 0.22 μm poresize filter to remove insoluble particles, they were spotted on a Article Title: Development of a Sensitive Microarray Platform for the Ranking of Galectin Inhibitors: Identification of a Selective Galectin-3 Inhibitor. Article Snippet: Deregulation of the expression of galectins, a family of lectins known to bind b-galactoside motifs through one or two highly conserved carbohydrate recognition domains (CRDs), has been shown to be either directly or indirectly associated to more than 130 human pathologies, spanning from inflammatory diseases, infectious diseases, diabetes, and heart failure to cancer.. As a consequence, interfering with galectin–ligand interaction has been proposed as a potential novel therapeutic strategy or, at least, as a practical means to delineate the roles of the galectins played in fundamental biological processes.. These goals can be achieved by using small-molecule inhibitors. Microarray:Article Title: Glycoconjugate microarray based on an evanescent-field fluorescence-assisted detection principle for investigation of glycan-binding proteins. Article Snippet: After filtration using 0.22 μm poresize filter to remove insoluble particles, they were spotted on a Article Title: Development of a Sensitive Microarray Platform for the Ranking of Galectin Inhibitors: Identification of a Selective Galectin-3 Inhibitor. Article Snippet: Deregulation of the expression of galectins, a family of lectins known to bind b-galactoside motifs through one or two highly conserved carbohydrate recognition domains (CRDs), has been shown to be either directly or indirectly associated to more than 130 human pathologies, spanning from inflammatory diseases, infectious diseases, diabetes, and heart failure to cancer.. As a consequence, interfering with galectin–ligand interaction has been proposed as a potential novel therapeutic strategy or, at least, as a practical means to delineate the roles of the galectins played in fundamental biological processes.. These goals can be achieved by using small-molecule inhibitors. |